These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9667652

  • 1. Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
    Nakata B, Chung KH, Kato Y, Yamashita Y, Inui A, Arimoto Y, Maeda K, Onoda N, Sawada T, Sowa M.
    Br J Cancer; 1998 Jun; 77(11):1820-4. PubMed ID: 9667652
    [Abstract] [Full Text] [Related]

  • 2. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N.
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [Abstract] [Full Text] [Related]

  • 3. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
    Wang L, Wang JH, Liu WJ, Wang WD, Wang H, Chen XQ, Geng QR, Lu Y, Xia ZJ.
    Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 6. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W, Chyczewska E.
    Folia Histochem Cytobiol; 2001 Aug; 39 Suppl 2():185-6. PubMed ID: 11820599
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Aug; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 8. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y, Takada K, Noda M, Satou T, Hashiba H, Miyachi A, Ito S, Iijima N, Yamamoto M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of soluble interleukin-2 receptor in renal cell carcinoma.
    Matsumoto T, Furukawa A, Sumiyoshi Y, Akiyama KY, Kanayama HO, Kagawa S.
    Urology; 1998 Jan; 51(1):145-9. PubMed ID: 9457310
    [Abstract] [Full Text] [Related]

  • 10. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
    Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M.
    Cancer; 1994 Jun 01; 73(11):2753-8. PubMed ID: 8194016
    [Abstract] [Full Text] [Related]

  • 11. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G.
    Cytokine; 2006 Feb 07; 33(3):150-5. PubMed ID: 16517174
    [Abstract] [Full Text] [Related]

  • 12. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
    Morita-Fujita M, Katoh D, Shimomura Y, Ishikawa T.
    Clin Lymphoma Myeloma Leuk; 2019 Jul 07; 19(7):e337-e342. PubMed ID: 31053551
    [Abstract] [Full Text] [Related]

  • 13. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
    Goto H, Tsurumi H, Takemura M, Ino-Shimomura Y, Kasahara S, Sawada M, Yamada T, Hara T, Fukuno K, Goto N, Okuno M, Takami T, Seishima M, Moriwaki H.
    J Cancer Res Clin Oncol; 2005 Feb 07; 131(2):73-9. PubMed ID: 15503137
    [Abstract] [Full Text] [Related]

  • 14. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
    Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC, Mills GB.
    Cancer; 1995 Nov 01; 76(9):1615-20. PubMed ID: 8635066
    [Abstract] [Full Text] [Related]

  • 15. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer.
    Maeta M, Saito H, Katano K, Kondo A, Tsujitani S, Makino M, Ikeguchi M, Kaibara N.
    Int J Mol Med; 1998 Jan 01; 1(1):113-6. PubMed ID: 9852207
    [Abstract] [Full Text] [Related]

  • 16. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
    Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME.
    Arch Dermatol; 1996 Jan 01; 132(1):42-7. PubMed ID: 8546482
    [Abstract] [Full Text] [Related]

  • 17. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
    Goto N, Tsurumi H, Goto H, Shimomura YI, Kasahara S, Hara T, Yasuda I, Shimizu M, Murakami N, Yoshikawa T, Fukuno K, Takahashi T, Kito Y, Takami T, Moriwaki H.
    Ann Hematol; 2012 May 01; 91(5):705-714. PubMed ID: 22183251
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 May 01; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 19. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
    Akiyama K, Tsuji M, Kurokawa Y, Yokota K, Kojima K, Naruo S, Kanayana HO, Kagawa S.
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr 01; 88(4):473-8. PubMed ID: 9155114
    [Abstract] [Full Text] [Related]

  • 20. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M, Darwish NA, Abdel-Aziz O.
    J Soc Gynecol Investig; 1996 Apr 01; 3(1):39-46. PubMed ID: 8796806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.